- Home
- DLTH vs ADVM Comparison
DLTH vs ADVM Comparison
Compare DLTH & ADVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DLTH
- ADVM
- Stock Information
- Founded
- DLTH 1989
- ADVM 2006
- Country
- DLTH United States
- ADVM United States
- Employees
- DLTH N/A
- ADVM N/A
- Industry
- DLTH Clothing/Shoe/Accessory Stores
- ADVM Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DLTH Consumer Discretionary
- ADVM Health Care
- Exchange
- DLTH Nasdaq
- ADVM Nasdaq
- Market Cap
- DLTH 80.4M
- ADVM 66.3M
- IPO Year
- DLTH 2015
- ADVM 2014
- Fundamental
- Price
- DLTH $2.31
- ADVM $3.04
- Analyst Decision
- DLTH Hold
- ADVM Strong Buy
- Analyst Count
- DLTH 1
- ADVM 4
- Target Price
- DLTH $2.75
- ADVM $19.75
- AVG Volume (30 Days)
- DLTH 27.0K
- ADVM 92.7K
- Earning Date
- DLTH 09-04-2025
- ADVM 08-12-2025
- Dividend Yield
- DLTH N/A
- ADVM N/A
- EPS Growth
- DLTH N/A
- ADVM N/A
- EPS
- DLTH N/A
- ADVM N/A
- Revenue
- DLTH $612,649,000.00
- ADVM $1,000,000.00
- Revenue This Year
- DLTH N/A
- ADVM $1,836.70
- Revenue Next Year
- DLTH $0.55
- ADVM N/A
- P/E Ratio
- DLTH N/A
- ADVM N/A
- Revenue Growth
- DLTH N/A
- ADVM N/A
- 52 Week Low
- DLTH $1.58
- ADVM $1.78
- 52 Week High
- DLTH $4.50
- ADVM $8.56
- Technical
- Relative Strength Index (RSI)
- DLTH 55.36
- ADVM 62.51
- Support Level
- DLTH $2.08
- ADVM $2.97
- Resistance Level
- DLTH $2.33
- ADVM $3.25
- Average True Range (ATR)
- DLTH 0.11
- ADVM 0.20
- MACD
- DLTH 0.00
- ADVM 0.04
- Stochastic Oscillator
- DLTH 74.07
- ADVM 81.90
About DLTH Duluth Holdings Inc. Class B
Duluth Holdings Inc is an apparel brand in the United States. The company offers shirts, pants, and casual wear for men and women under brands like Alaskan Hardgear, Armachillo, Ballroom, Cab Commander, Crouch Gusset, Dry on the Fly, Duluth Trading Co, Duluthflex, Fire Hose, Longtail T, No Polo Shirt, No Yank, Wild Boar, and others. The Company's revenue consists of the sale of apparel, footwear, and hard goods. The company operates in a single operating segment.
About ADVM Adverum Biotechnologies Inc.
Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.